IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v391y1998i6670d10.1038_36116.html
   My bibliography  Save this article

Disruption of IRS-2 causes type 2 diabetes in mice

Author

Listed:
  • Dominic J. Withers

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Julio Sanchez Gutierrez

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Heather Towery

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Deborah J. Burks

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Jian-Ming Ren

    (Howard Hughes Medical Institute, Yale University School of Medicine)

  • Stephen Previs

    (Howard Hughes Medical Institute, Yale University School of Medicine)

  • Yitao Zhang

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Dolores Bernal

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Sebastian Pons

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Gerald I. Shulman

    (Howard Hughes Medical Institute, Yale University School of Medicine)

  • Susan Bonner-Weir

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

  • Morris F. White

    (Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School)

Abstract

Human type 2 diabetes is characterized by defects in both insulin action and insulin secretion. It has been difficult to identify a single molecular abnormality underlying these features. Insulin-receptor substrates (IRS proteins) may be involved in type 2 diabetes: they mediate pleiotropic signals initiated by receptors for insulin and other cytokines1. Disruption of IRS-1 in mice retards growth, but diabetes does not develop because insulin secretion increases to compensate for the mild resistance to insulin2,3. Here we show that disruption of IRS-2 impairs both peripheral insulin signalling and pancreatic β-cell function. IRS-2-deficient mice show progressive deterioration of glucose homeostasis because of insulin resistance in the liver and skeletal muscle and a lack of β-cell compensation for this insulin resistance. Our results indicate that dysfunction of IRS-2 may contribute to the pathophysiology of human type 2 diabetes.

Suggested Citation

  • Dominic J. Withers & Julio Sanchez Gutierrez & Heather Towery & Deborah J. Burks & Jian-Ming Ren & Stephen Previs & Yitao Zhang & Dolores Bernal & Sebastian Pons & Gerald I. Shulman & Susan Bonner-Wei, 1998. "Disruption of IRS-2 causes type 2 diabetes in mice," Nature, Nature, vol. 391(6670), pages 900-904, February.
  • Handle: RePEc:nat:nature:v:391:y:1998:i:6670:d:10.1038_36116
    DOI: 10.1038/36116
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/36116
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/36116?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Vinod Nikhra, 2019. "Exploring the Mechanism of Insulin Action, Differential Insulin Sensitivity and Insulin Resistance," Current Research in Diabetes & Obesity Journal, Juniper Publishers Inc., vol. 12(2), pages 23-31, October.
    2. Yue Hu & Min Zhou & Kai Zhang & Xiangquan Kong & Xiaoyan Hu & Kang Li & Li Liu, 2014. "Lack of Association between Insulin Receptor Substrate2 rs1805097 Polymorphism and the Risk of Colorectal and Breast Cancer: A Meta-Analysis," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-7, January.
    3. Xiaoyun Lei & Shi Huang, 2017. "Enrichment of minor allele of SNPs and genetic prediction of type 2 diabetes risk in British population," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-13, November.
    4. Preetam Guha Ray & Debasis Maity & Jinbo Huang & Henryk Zulewski & Martin Fussenegger, 2023. "A versatile bioelectronic interface programmed for hormone sensing," Nature Communications, Nature, vol. 14(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:391:y:1998:i:6670:d:10.1038_36116. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.